Effects of reconstituted HDL cholesterol infusions on measurements of atherosclerosis
This article has no abstract so we have provided the first paragraph of the full text.
Epidemiological studies have shown an inverse association between elevated HDL cholesterol (HDLC) level and risk of coronary atherosclerotic disease. Tardif et al. performed a randomized, double-blind, placebo-controlled trial to investigate the safety and efficacy of reconstituted HDLC.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
